|
There is a very highly undervalued stock that no one knows about pending human trials. Its a great buy. The stock is MSBT.
MedaSorb Technologies Corporation (MSBT) target PPS of $16 per share. Currently trading very low. The target price upcoming is to be up to $1 within one month. Also, upcoming conference. Check Press release that came out today: http://www.cnbc.com/id/33374987/site/140... There is a complete analysis of this stock on http://tapebeat.com/News/medasorb-draws-... What do you guys think? Rating :
  (3 Ratings) |
30/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
Messages in Topic
| Subject | Author | Rating | Time of Post (ET) | ||
|---|---|---|---|---|---|
|
Great undervalued stock pending human trial results: MS...
|
nitr05 |
 
|
19-Oct-09 10:49 pm |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.0899